SecurityGSK / GlaxoSmithKline plc
InstitutionWells Fargo & Company/mn
Shares6,806,494
Value $ 274,371,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Wells Fargo & Company/mn reports 2.52% decrease in ownership of GSK / GlaxoSmithKline plc

August 01, 2018 - Wells Fargo & Company/mn has filed a 13F-HR form disclosing ownership of 6,806,494 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $274,371,000 USD as of June 30, 2018. Wells Fargo & Company/mn had filed a previous 13F-HR on May 02, 2018 disclosing 6,982,366 shares of GlaxoSmithKline plc at a value of $272,801,000 USD. This represents a change in shares of -2.52 percent and a change in value of 0.58 percent during the quarter.

Wells Fargo & Company/mn has a history of taking positions in derivatives of the underlying security (GSK) in the form of stock options. The firm currently holds 0 call options valued at $0 USD and 360,400 put options valued at $339,000 USD .

Other investors with positions similar to Wells Fargo & Company/mn include Bank Of America Corp /de/, Black Creek Investment Management Inc., Renaissance Technologies LLC, Federated Investors Inc /pa/, Hotchkis & Wiley Capital Management Llc, and Raymond James & Associates.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.69 6,806,494 -2.52 274,371 0.58 -6,980 8,550 3.13
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 37.27 6,982,366 -2.43 272,801 7.47 -6,480 25,449 10.03
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 38.04 7,156,220 -42.75 253,832 -49.98 -203,237 -50,416 -9.93
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.86 12,499,633 4.32 507,485 -1.78 21,658 -30,847 -5.97
2017-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 42.64 11,982,247 2.81 516,674 5.15 13,960 11,346 2.31
2017-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.34 11,654,851 15.97 491,368 26.96 64,732 39,610 10.23
2016-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.82 10,050,002 -1.85 387,026 -12.36 -7,739 -46,868 -10.61
2016-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 43.24 10,239,594 -14.81 441,633 -15.22 -76,945 -2,339 -0.45
2016-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.94 12,019,282 4.66 520,917 11.86 22,438 32,790 7.04
2016-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.45 11,484,346 7.66 465,689 8.20 33,072 2,215 0.51
2015-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.40 10,666,746 -0.70 430,402 4.21 -2,944 20,336 4.92
2015-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.05 10,741,458 -4.28 413,010 -11.64 -19,249 -35,141 -7.52
2015-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 43.90 11,222,072 3.49 467,400 -6.60 16,601 -49,649 -9.92
2015-03-31 13F-HR/A-1 GLAXOSMITHKLINE SPONSORED ADR 37733W105 44.44 10,843,919 12.74 500,448 21.74 54,477 34,890 8.49
2015-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 10,843,919 500,448
2014-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 44.36 9,618,206 6.47 411,081 -1.01 25,910 -30,125 -7.25
2014-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 49.73 9,034,053 6.00 415,296 -8.89 25,427 -65,927 -14.46
2014-06-30 13F-HR/A-1 GLAXOSMITHKLINE SPONSORED ADR 37733W105 53.46 8,522,706 0.63 455,796 0.73 2,860 429 0.09
2014-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 8,522,706 455,796
2014-03-31 13F-HR/A-1 GLAXOSMITHKLINE SPONSORED ADR 37733W105 53.43 8,469,194 0.00 452,507 0.00 0 0 0.00
2014-03-31 13F-HR/A-2 GLAXOSMITHKLINE SPONSORED ADR 37733W105 8,469,194 452,507

Call Options

Effective
Date
Form Security Class CUSIP Opt Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2016-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Call 0 -100.00 0 -100.00 0 0
2015-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Call 30,200 10

Put Options

Effective
Date
Form Security Class CUSIP Opt Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 1.44 360,400 125.67 339 9.71 289 -259 -83.67
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 1.98 159,700 -81.98 309 -82.86 -1,442 -52 -2.90
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 1.27 886,000 0.00 1,803 305.17 0 1,358 305.17
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 0.49 886,000 12.72 445 19.30 49 23 6.21
2017-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 0.73 786,000 0.00 373 -51.56 0 -397 -51.56
2017-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 2.31 786,000 -30.75 770 -81.41 -808 -2,563 -61.90
2016-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 2.91 1,135,000 7.58 4,141 80.44 233 1,613 70.29
2016-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 2.57 1,055,000 39.74 2,295 2.68 770 -710 -31.78
2016-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 3.22 755,000 36.04 2,235 15.86 644 -338 -17.50
2016-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 3.44 555,000 48.20 1,929 51.18 621 32 2.49
2015-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 4.53 374,500 0.00 1,276 -39.81 0 -844 -39.81
2015-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 4.67 374,500 0.00 2,120 54.07 0 744 54.07
2015-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 2.89 374,500 71.71 1,376 199.78 452 465 101.33
2015-03-31 13F-HR/A GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 3.12 218,100 0.00 459 -49.00 0 -441 -49.00
2015-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 218,100 459
2014-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 3.69 218,100 0.00 900 26.94 0 191 26.94
2014-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 Put 218,100 709


CUSIP: 37733W105